Fatty Acid Binding Protein-4 Silencing Inhibits Ferroptosis to Alleviate Lipopolysaccharide-induced Injury of Renal Tubular Epithelial Cells by Blocking Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Xu S;Xu S; Luo J; Wang Y; Chen X
  • Source:
    Journal of physiological investigation [J Physiol Investig] 2024 Jan 01; Vol. 67 (1), pp. 47-56. Date of Electronic Publication: 2024 Feb 28.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Wolters Kluwer - Medknow Country of Publication: India NLM ID: 9918803386606676 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2950-6344 (Print) Linking ISSN: 29506344 NLM ISO Abbreviation: J Physiol Investig Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Mumbai] : Wolters Kluwer - Medknow, [2024]-
    • Subject Terms:
    • Abstract:
      Sepsis-induced kidney injury (SAKI) has been frequently established as a prevailing complication of sepsis which is linked to unfavorable outcomes. Fatty acid-binding protein-4 (FABP4) has been proposed as a possible target for the treatment of SAKI. In the current work, we aimed to explore the role and underlying mechanism of FABP4 in lipopolysaccharide (LPS)-induced human renal tubular epithelial cell damage. In LPS-induced human kidney 2 (HK2) cells, FABP4 expression was tested by the reverse transcription-quantitative polymerase chain reaction and Western blot. Cell counting kit-8 method assayed cell viability. Inflammatory levels were detected using the enzyme-linked immunosorbent assay. Immunofluorescence staining measured the nuclear translocation of nuclear factor kappa B p65. Thiobarbituric acid-reactive substances assay and C11 BODIPY 581/591 probe were used to estimate the level of cellular lipid peroxidation. Fe2+ content was examined by the kit. In addition, the expression of proteins related to inflammation-, ferroptosis- and Janus kinase 2 (JAK2)/signal transducer, and activator of transcription 3 (STAT3) signaling was detected by the Western blot analysis. The results revealed that FABP4 was significantly upregulated in LPS-treated HK2 cells, the knockdown of which elevated the viability, whereas alleviated the inflammation and ferroptosis in HK2 cells challenged with LPS. In addition, down-regulation of FABP4 inactivated JAK2/STAT3 signaling. JAK2/STAT3 stimulator (colivelin) and ferroptosis activator (Erastin) partially restored the effects of FABP4 interference on LPS-triggered inflammation and ferroptosis in HK2 cells. Together, FABP4 knockdown inhibited ferroptosis to alleviate LPS-induced injury of renal tubular epithelial cells through suppressing JAK2/STAT3 signaling.
      (Copyright © 2024 Copyright: © 2024 Journal of Physiological Investigation.)
    • References:
      Salomão R, Ferreira BL, Salomão MC, Santos SS, Azevedo LC, Brunialti MK. Sepsis:Evolving concepts and challenges. Braz J Med Biol Res 2019;52:e8595.
      Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ 2019;364:k4891.
      Sun J, Zhang J, Tian J, Virzì GM, Digvijay K, Cueto L, et al. Mitochondria in sepsis-induced AKI. J Am Soc Nephrol 2019;30:1151–61.
      Prowle JR. Sepsis-associated AKI. Clin J Am Soc Nephrol 2018;13:339–42.
      Hoste EA, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol 2018;14:607–25.
      An N, Chen R, Bai Y, Xu M. Efficacy and prognosis of continuous renal replacement therapy at different times in the treatment of patients with sepsis-induced acute kidney injury. Am J Transl Res 2021;13:7124–31.
      Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis:Machinery and regulation. Autophagy 2021;17:2054–81.
      Guo J, Wang R, Min F. Ginsenoside Rg1 ameliorates sepsis-induced acute kidney injury by inhibiting ferroptosis in renal tubular epithelial cells. J Leukoc Biol 2022;112:1065–77.
      Qiu W, An S, Wang T, Li J, Yu B, Zeng Z, et al. Melatonin suppresses ferroptosis via activation of the Nrf2/HO-1 signaling pathway in the mouse model of sepsis-induced acute kidney injury. Int Immunopharmacol 2022;112:109162.
      Li B, Hao J, Zeng J, Sauter ER. SnapShot:FABP functions. Cell 2020;182:1066.e1.
      Moseti D, Regassa A, Kim WK. Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules. Int J Mol Sci 2016;17:124.
      Furuhashi M. Fatty acid-binding protein 4 in cardiovascular and metabolic diseases. J Atheroscler Thromb 2019;26:216–32.
      Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs –Mechanisms and therapeutic implications. Nat Rev Endocrinol 2015;11:592–605.
      Frances L, Tavernier G, Viguerie N. Adipose-derived lipid-binding proteins:The good, the bad and the metabolic diseases. Int J Mol Sci 2021;22:10460.
      Hu B, Li Y, Gao L, Guo Y, Zhang Y, Chai X, et al. Hepatic induction of fatty acid binding protein 4 plays a pathogenic role in sepsis in mice. Am J Pathol 2017;187:1059–67.
      Liu J, Huang R, Li X, Guo F, Li L, Zeng X, et al. Genetic inhibition of FABP4 attenuated endoplasmic reticulum stress and mitochondrial dysfunction in rhabdomyolysis-induced acute kidney injury. Life Sci 2021;268:119023.
      Huang R, Shi M, Guo F, Feng Y, Feng Y, Liu J, et al. Pharmacological inhibition of fatty acid-binding protein 4 (FABP4) protects against rhabdomyolysis-induced acute kidney injury. Front Pharmacol 2018;9:917.
      Wang B, Xu J, Ren Q, Cheng L, Guo F, Liang Y, et al. Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis. Cell Death Dis 2022;13:333.
      Fan X, Xu M, Ren Q, Fan Y, Liu B, Chen J, et al. Downregulation of fatty acid binding protein 4 alleviates lipid peroxidation and oxidative stress in diabetic retinopathy by regulating peroxisome proliferator-activated receptor g-mediated ferroptosis. Bioengineered 2022;13:10540–51.
      Chen J, Wu K, Lei Y, Huang M, Cheng L, Guan H, et al. Inhibition of fatty acid b-oxidation by fatty acid binding protein 4 induces ferroptosis in HK2 cells under high glucose conditions. Endocrinol Metab (Seoul) 2023;38:226–44.
      Huang B, Lang X, Li X. The role of IL-6/JAK2/STAT3 signaling pathway in cancers. Front Oncol 2022;12:1023177.
      Tan Z, Liu Q, Chen H, Zhang Z, Wang Q, Mu Y, et al. Pectolinarigenin alleviated septic acute kidney injury via inhibiting Jak2/Stat3 signaling and mitochondria dysfunction. Biomed Pharmacother 2023;159:114286.
      Zhou Y, Xu W, Zhu H. CXCL8((3-72)) K11R/G31P protects against sepsis-induced acute kidney injury via NF-kB and JAK2/STAT3 pathway. Biol Res 2019;52:29.
      Xu L, Zhang H, Wang Y, Yang A, Dong X, Gu L, et al. FABP4 activates the JAK2/STAT2 pathway via Rap1a in the homocysteine-induced macrophage inflammatory response in ApoE(-/-) mice atherosclerosis. Lab Invest 2022;102:25–37.
      Li S, Xu Z, Guo J, Zheng J, Sun X, Yu J. Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2/STAT3 signalling via transactivation of SOCS3 gene. J Cell Mol Med 2020;24:14549–60.
      Zhang Q, Hu Y, Hu JE, Ding Y, Shen Y, Xu H, et al. Sp1-mediated upregulation of Prd×6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis. Life Sci 2021;278:119529.
      He Y, Sun Y, Peng J. Circ_0114428 regulates sepsis-induced kidney injury by targeting the miR-495-3p/CRBN axis. Inflammation 2021;44:1464–77.
      Zarbock A, Gomez H, Kellum JA. Sepsis-induced acute kidney injury revisited:Pathophysiology, prevention and future therapies. Curr Opin Crit Care 2014;20:588–95.
      Pérez-Hernández EG, Delgado-Coello B, Luna-Reyes I, Mas-Oliva J. New insights into lipopolysaccharide inactivation mechanisms in sepsis. Biomed Pharmacother 2021;141:111890.
      Gong J, Zhao S, Luo S, Yin S, Li X, Feng Y. Downregulation of circ-ZNF644 alleviates LPS-induced HK2 cell injury via miR-335-5p/HIPK1 axis. Environ Toxicol 2022;37:2855–64.
      Tan C, Gu J, Li T, Chen H, Liu K, Liu M, et al. Inhibition of aerobic glycolysis alleviates sepsis-induced acute kidney injury by promoting lactate/Sirtuin 3/AMPK-regulated autophagy. Int J Mol Med 2021;47:19.
      Cantaluppi V, Quercia AD, Dellepiane S, Ferrario S, Camussi G, Biancone L. Interaction between systemic inflammation and renal tubular epithelial cells. Nephrol Dial Transplant 2014;29:2004–11.
      Zhou X, Zhou S, Tao J, Gao Y, Meng G, Cao D, et al. HIV-1 tat drives the Fabp4/NF-kB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis. J Neurovirol 2022;28:483–96.
      Zhang W, Zhang Y, Zhu Q. Cigarette smoke extract-mediated FABP4 upregulation suppresses viability and induces apoptosis, inflammation and oxidative stress of bronchial epithelial cells by activating p38 MAPK/MK2 signaling pathway. J Inflamm (Lond) 2022;19:7.
      Poma P. NF-kB and disease. Int J Mol Sci 2020;21.
      Martins GR, Gelaleti GB, Moschetta MG, Maschio-Signorini LB, Zuccari DA. Proinflammatory and anti-inflammatory cytokines mediated by NF-kB factor as prognostic markers in mammary tumors. Mediators Inflamm 2016;2016:9512743.
      Sanz AB, Sanchez-Niño MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M, et al. NF-kappaB in renal inflammation. J Am Soc Nephrol 2010;21:1254–62.
      Zhang H, Sun SC. NF-kB in inflammation and renal diseases. Cell Biosci 2015;5:63.
      Tak PP, Firestein GS. NF-kappaB:A key role in inflammatory diseases. J Clin Invest 2001;107:7–11.
      Hayden MS, Ghosh S. Regulation of NF-kB by TNF family cytokines. Semin Immunol 2014;26:253–66.
      Shum HP, Yan WW, Chan TM. Recent knowledge on the pathophysiology of septic acute kidney injury:A narrative review. J Crit Care 2016;31:82–9.
      Liu X, Chen C, Han D, Zhou W, Cui Y, Tang X, et al. SLC7A11/GPX4 Inactivation-mediated ferroptosis contributes to the pathogenesis of triptolide-induced cardiotoxicity. Oxid Med Cell Longev 2022;2022:3192607.
      Fang Y, Chen X, Tan Q, Zhou H, Xu J, Gu Q. Inhibiting ferroptosis through disrupting the NCOA4-FTH1 interaction:A new mechanism of action. ACS Cent Sci 2021;7:980–9.
      Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 2017;13:91–8.
      Huo L, Liu C, Yuan Y, Liu X, Cao Q. Pharmacological inhibition of ferroptosis as a therapeutic target for sepsis-associated organ damage. Eur J Med Chem 2023;257:115438.
      Tang Y, Luo H, Xiao Q, Li L, Zhong X, Zhang J, et al. Isoliquiritigenin attenuates septic acute kidney injury by regulating ferritinophagy-mediated ferroptosis. Ren Fail 2021;43:1551–60.
      Zhang C, Liu J, Yuan C, Ji Q, Chen D, Zhao H, et al. JAK2/STAT3 is associated with the inflammatory process in periapical granuloma. Int J Clin Exp Pathol 2019;12:190–7.
      Li X, Liu J. FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma. BMC Cancer 2023;23:179.
      Jaśkiewicz A, Domoradzki T, Pająk B. Targeting the JAK2/STAT3 Pathway-can we compare it to the two faces of the god Janus?. Int J Mol Sci 2020;21:8261.
      Zhao Y, Wang C, Yang T, Wang H, Zhao S, Sun N, et al. Chlorogenic acid alleviates chronic stress-induced duodenal ferroptosis via the inhibition of the IL-6/JAK2/STAT3 signaling pathway in rats. J Agric Food Chem 2022;70:4353–61.
      Luo Q, Zheng J, Fan B, Liu J, Liao W, Zhang X. Enriched environment attenuates ferroptosis after cerebral ischemia/reperfusion injury by regulating iron metabolism. Brain Res Bull 2023;203:110778.
      Shi M, Guo F, Liao D, Huang R, Feng Y, Zeng X, et al. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy. Eur J Pharmacol 2020;887:173570.
    • Accession Number:
      0 (FABP4 protein, human)
      0 (Fatty Acid-Binding Proteins)
      EC 2.7.10.2 (JAK2 protein, human)
      EC 2.7.10.2 (Janus Kinase 2)
      0 (Lipopolysaccharides)
      0 (STAT3 protein, human)
      0 (STAT3 Transcription Factor)
    • Publication Date:
      Date Created: 20240523 Date Completed: 20240523 Latest Revision: 20240903
    • Publication Date:
      20240904
    • Accession Number:
      10.4103/EJPI.EJPI-D-23-00027
    • Accession Number:
      38780272